Definitive Contract 75N93021C00032
Award Date
8/16/21
Potential Completion Date
8/15/22
Potential Value
$297K
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
Adaptive Phage Therapeutics, LLC
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Available for Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Westlake, MD 20817, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
6
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a Firm Fixed Price Definitive Contract to CFD Research Corporation, a for-profit organization, to perform Phase I SBIR research on a "SMART BIOREACTOR FOR LARGE-SCALE HIGH TITER PHAGE PREPS" project. The contract has a potential value of $299,946.26 and a completion date of August 15, 2022. This SBIR award was not set aside for a specific business...
This $1,797,717.00 Small Business Innovation Research (SBIR) Phase I contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the National Institutes of Health (NIH), to Intralytix Inc., a biotechnology company specializing in bacteriophage-based products. The contract is for the development of a "Universal, Scalable Artificial Intelligence-Based Platform for Manufacturing High Titer Biopharmaceuticals", which aligns with...
This $297,740 Small Business Innovation Research (SBIR) Phase I contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to CFD Research Corporation, a small business in Huntsville, Alabama. The contract is for the "Development of Bacteriophage for Treatment of Mycobacterial Infections", under SBIR Topic 131 from the SBIR/STTR solicitation PHS-2023-1. CFD Research specializes in engineering...
This is a $300,000 Firm Fixed Price contract awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Vitruvian Bio, LLC, a small disadvantaged woman-owned business. The contract is for a Small Business Innovation Research (SBIR) Phase I project to be completed by June 30, 2023. The award is associated with a larger SBIR solicitation that sought innovative research proposals from small businesses to...
This is a $575,850.00 fixed-price delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under the In Vitro Antimicrobial Assessments 2011-2018 indefinite-delivery, indefinite-quantity (IDIQ) contract. The contract was awarded to Access To Advanced Health Institute (AAHI), a nonprofit biotech research institute located in Seattle, Washington. The contract is for unspecified "OTHER FUNCTIONS" and does not have a set-aside designation. As a prime...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $119,600 firm fixed price delivery order against the In Vitro Assessments of Antimicrobial Activity indefinite-delivery/indefinite-quantity contract vehicle. Under this order, the American Type Culture Collection will perform in vitro inhibitory effect determinations of experimental antibacterial substances against biodefense bacteria species including...
The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) awarded a firm fixed-price purchase order to Adaptive Biotechnologies Corporation, doing business as Adaptive, for $37,820.00. The contract is for immunosequencing services, including T-cell receptor alpha/delta (TCRA/D) and B-cell repertoire (HSTCRB) sequencing, to analyze diversity of these cells in primary immunodeficiency research. The award...
This firm fixed price definitive contract for $300,000 was awarded by the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases to Innov8Ai, a for-profit small business, to advance the agency's mission through research and development. The contract is associated with the Small Business Innovation Research Program Phase I solicitation to capture medical misinformation in social media for targeted interdiction using an...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $300,000 definitive contract to Antagen Biosciences Inc., doing business as Antagen Pharmaceuticals, as part of the Small Business Innovation Research Program Phase I Action. The contract is a firm fixed price award with a period of performance from July 5, 2022 through November 30, 2023 to be performed in Canton, Massachusetts. The award is set aside for...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases (HHS-NIH-NIAID) awarded a $298,596 definitive contract to Sanaria Inc. of Potomac, MD for Research Type Small Business Innovation Research Program Phase I Action. The contract is a firm fixed price award with a period of performance from August 30, 2022 through April 1, 2024. The place of performance is Potomac, MD and the contract has a total small business set aside...